Novartis names firmenich CEO as Sandoz chairman

Novartis on Monday announced the appointment of Gilbert Gostin as chairman of the board of Sandoz, the generics division that Novartis wants to spin off later this year.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner